US 10632173
Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
granted A61KA61K38/1703A61K38/1709
Quick answer
US patent 10632173 (Formulations and methods of use for alpha connexin C-terminal (ACT) peptides) held by FIRSTRING RESEARCH, INC. expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- FIRSTRING RESEARCH, INC.
- Grant date
- Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/1703, A61K38/1709, A61K38/1767, A61K38/177